X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XFOR | FBRX | IRD | ||
| Company | X4 Pharmaceuticals Inc | Forte Biosciences Inc | Opus Genetics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.22 | 28.22 | 5.21 | ||
| High | 4.28 | 28.48 | 5.39 | ||
| Low | 4.03 | 27.17 | 4.94 | ||
| Latest | 4.11 | 27.45 | 5.23 | ||
| Change | -0.17 | -1.41 | +0.02 | ||
| % Change | -3.97% | -4.89% | +0.38% | ||
| Volume | 527,000 | 189,000 | 655,400 | ||
| 20-Day Average Volume | 408,525 | 423,105 | 653,525 | ||
| Previous Close | 4.28 | 28.86 | 5.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.15 | 29.45 | 5.16 | ||
| 20-Day Raw Stochastic | 42.71% | 34.10% | 62.94% | ||
| 20-Day Relative Strength | 51.05 | 46.86 | 56.93 | ||
| Weighted Alpha | -26.84 | +71.72 | +461.23 | ||
| Today's Opinion | 88% Buy | 56% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.20% since 04/17/26 | -19.07% since 04/17/26 | -9.04% since 04/17/26 | ||
| Low | 4.03 on 04/24/26 | 27.17 on 04/24/26 | 4.94 on 04/24/26 | ||
| High | 4.66 on 04/23/26 | 34.82 on 04/21/26 | 5.70 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +7.59% since 03/24/26 | +6.73% since 03/24/26 | +15.96% since 03/24/26 | ||
| Low | 3.70 on 04/07/26 | 23.13 on 04/01/26 | 4.24 on 03/30/26 | ||
| High | 4.66 on 04/23/26 | 35.80 on 04/09/26 | 5.81 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +11.08% since 01/23/26 | -13.95% since 01/23/26 | +104.30% since 01/23/26 | ||
| Low | 2.83 on 02/18/26 | 22.01 on 03/20/26 | 2.21 on 02/05/26 | ||
| High | 4.83 on 03/10/26 | 35.80 on 04/09/26 | 5.81 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +8.16% since 10/24/25 | +126.67% since 10/24/25 | +162.81% since 10/24/25 | ||
| Low | 2.83 on 02/18/26 | 10.30 on 11/05/25 | 1.70 on 11/18/25 | ||
| High | 4.83 on 03/10/26 | 35.80 on 04/09/26 | 5.81 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 373,681 | 381,170 | 373,432 | ||
| Shares Outstanding, K | 90,920 | 13,886 | 71,402 | ||
| Annual Sales | 35,110,000 | 0 | 14,200,000 | ||
| Annual Net Income | -79,200,000 | -69,380,000 | -49,590,000 | ||
| Last Quarter Sales | 2,570,000 | 0 | 3,870,000 | ||
| Last Quarter Net Income | -23,930,000 | -24,790,000 | -16,520,000 | ||
| 60-Month Beta | 0.32 | 3.20 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 03/17/26 | -1.45 on 03/31/26 | -0.14 on 03/10/26 | ||
| Latest Earnings Date | 05/07/26 | 05/21/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||